ARTICLE | Company News
Archimedes submits NasalFent MAA
April 28, 2009 1:32 AM UTC
Archimedes Pharma Ltd. (Reading, U.K.) submitted an MAA to EMEA for NasalFent fentanyl nasal spray to treat breakthrough cancer pain. NasalFent uses the company's PecSys nasal spray drug delivery syst...